ROBERT T SPENCER M.D. NPI 1497787352

NPI Details

Robert T Spencer, M.D. is a rheumatology internal medicine in Englewood, CO with 33 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Robert T Spencer, M.D. NPI is 1497787352. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE
Graduation Year:1992

The provider's business location address is:

701 E HAMPDEN AVE
STE 410
ENGLEWOOD, CO
ZIP 80113-736
Phone: (303) 788-1312
Fax: (303) 788-1967

The NPI 1497787352 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, triamcinolone hexacetonide, per 5 mg (HCPCS:J3303)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)

The enumeration date for this NPI number is 7/7/2006 and was last updated on 9/27/2013.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.